Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Barrier-to-autointegration factor 1 (BANF1) is a highly conserved, small, non-specific DNA-binding protein found in multicellular eukaryotes[1][2][3][4][5]. BANF1 functions as a homodimer, binding to the phosphate backbone of double-stranded DNA and compacting DNA, which helps maintain chromatin organization and genome stability[1][2][3]. It is a critical component of the nuclear envelope, essential for both the assembly and disassembly of the nuclear envelope during cell division[1][2]. BANF1 interacts with key nuclear envelope proteins, including Lamin A, Emerin, and other LEM-domain proteins, anchoring chromatin to the nuclear periphery and regulating nuclear structure[1][2][4]. Loss or mutation of BANF1 leads to loss of nuclear envelope integrity, aberrant chromatin organization, and is genetically linked to the rare premature ageing disorder Néstor–Guillermo Progeria Syndrome (NGPS)[1][2][6]. BANF1 also regulates the DNA repair protein PARP1 and is involved in the DNA damage response, especially in oxidative stress[1][6]. Besides its DNA structural role, BANF1 prevents inappropriate activation of innate immune sensors during nuclear envelope rupture by outcompeting DNA sensors such as cGAS for double-stranded DNA binding[1]. BANF1 is not a typical therapeutic target (i.e., not a receptor, enzyme, transporter, or transcription factor) but is a structural nuclear assembly factor with broad importance in genome maintenance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Barrier-to-autointegration factor 1 (BANF1).